BIND Therapeutics Inc (NASDAQ:BIND)

7.52
Delayed Data
As of Apr 17
 -0.17 / -2.21%
Today’s Change
4.89
Today|||52-Week Range
13.72
+39.26%
Year-to-Date

Today’s Trading

Previous close7.69
Today’s open7.52
Day’s range7.31 - 7.64
Volume435,815
Average volume (3 months)428,940
Market cap$153.4M
Dividend yield--
Data as of 3:59pm ET, 04/17/2015

Growth & Valuation

Earnings growth (last year)+62.04%
Earnings growth (this year)-5.42%
Earnings growth (next 5 years)--
Revenue growth (last year)-4.36%
P/E ratioNM
Price/Sales8.54
Price/Book3.35

Competitors

 Today’s
change
Today’s
% change
KMDAKamada Ltd+0.01+0.22%
AUPHAurinia Pharmaceutic...-0.09-2.26%
BPTHBio Path Holdings In...-0.12-7.69%
CURNeuralstem Inc-0.15-6.88%
Data as of 4:00pm ET, 04/17/2015

Financials

Next reporting dateMay 7, 2015
EPS forecast (this quarter)-$0.55
Annual revenue (last year)$10.4M
Annual profit (last year)-$32.5M
Net profit margin-312.08%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Andrew J. Hirsch
Secretary, Treasurer &
Senior VP-Finance
Christopher M. Lindblom
Corporate headquarters
Cambridge, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers